Jaythoon Hassan
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Jaythoon Hassan has a total of 193 co-authors. Here are the top co-authors by number of shared publications:
Jeff Connell
17 shared publicationsWilliam W. Hall
National Virus Reference Laboratory, School of Medicine and Medical Science, University College Dublin, Belfield, Dublin 4, Ireland
9 shared publicationsA. Whelan
Department of Immunology, St James’s Hospital, Republic of Ireland
8 shared publicationsB. Bresnihan
Department of Rheumatology, St Vincent’s Hospital, Dublin, Republic of Ireland
8 shared publicationsC. Feighery
Department of Immunology, St James’s Hospital, Republic of Ireland
8 shared publications- Michael J. Carr
National Virus Reference Laboratory, University College Dublin, Dublin, Ireland
8 shared publications
Latest Publications
- Open Access
- 26 October 2026
- Published by Wiley in Pediatric Transplantation
- Vol. 30 (11) , e70491
Investigation of Torque Teno Virus Loads as a Marker of Immunosuppression in Pediatric Chronic Renal Failure: A Pilot Study
Background: Torque Teno Virus (TTV), family Anelloviridae , is a small, non‐enveloped, single‐stranded DNA virus that has not been linked with any specific human illness but nevertheless constitutes a major component of the human virome. An association between TTV loads and the immune status of the host with reference to other viral infections, immunosuppression therapy, and acute rejection is reported in adult and pediatric kidney transplant recipients. We sought to investigate the feasibility of TTV as a surrogate marker of the degree of immunosuppression in pediatric kidney transplant patients. Methods: 185 children attending the Nephrology clinic in Children's Health Ireland at Temple Street were studied over a four‐year period from September 2019 until November 2023, ranging from 0 to 17 years of age. Patients were enrolled from pre‐transplant undergoing kidney replacement therapy ( n = 12), from post‐transplant ( n = 124) groups, and from patients with chronic renal failure ( n = 20) (without kidney replacement therapy), all of which were compared to controls ( n = 35). TTV loads were quantified using a standardized TTV R‐gene kit. Results: TTV loads were significantly higher compared to controls from 3 months post‐transplantation onward ( p < 0.001), with the greatest increase observed between 3 and 6 months post‐transplantation. Immunosuppression exerted a significant independent effect on TTV loads after adjusting for age ( p < 0.001). Overall, females exhibited significantly higher TTV loads than males ( p = 0.01). Furthermore, a significant interaction was observed between patient group and gender ( p < 0.001). Conclusion: These findings suggest that both immunosuppressive status and gender‐related factors contribute to TTV kinetics after transplantation and should be considered when interpreting TTV as a biomarker of immune function. Larger studies are required to confirm our findings.
- 26 October 2026
- Published by Wiley in Pediatric Transplantation
- Vol. 30 (11) , e70491
Open AccessInvestigation of Torque Teno Virus Loads as a Marker of Immunosuppression in Pediatric Chronic Renal Failure: A Pilot Study
Background: Torque Teno Virus (TTV), family Anelloviridae , is a small, non‐enveloped, single‐stranded DNA virus that has not been linked with any specific human illness but nevertheless constitutes a major component of the human virome. An association between TTV loads and the immune status of the host with reference to other viral infections, immunosuppression therapy, and acute rejection is reported in adult and pediatric kidney transplant recipients. We sought to investigate the feasibility of TTV as a surrogate marker of the degree of immunosuppression in pediatric kidney transplant patients. Methods: 185 children attending the Nephrology clinic in Children's Health Ireland at Temple Street were studied over a four‐year period from September 2019 until November 2023, ranging from 0 to 17 years of age. Patients were enrolled from pre‐transplant undergoing kidney replacement therapy ( n = 12), from post‐transplant ( n = 124) groups, and from patients with chronic renal failure ( n = 20) (without kidney replacement therapy), all of which were compared to controls ( n = 35). TTV loads were quantified using a standardized TTV R‐gene kit. Results: TTV loads were significantly higher compared to controls from 3 months post‐transplantation onward ( p < 0.001), with the greatest increase observed between 3 and 6 months post‐transplantation. Immunosuppression exerted a significant independent effect on TTV loads after adjusting for age ( p < 0.001). Overall, females exhibited significantly higher TTV loads than males ( p = 0.01). Furthermore, a significant interaction was observed between patient group and gender ( p < 0.001). Conclusion: These findings suggest that both immunosuppressive status and gender‐related factors contribute to TTV kinetics after transplantation and should be considered when interpreting TTV as a biomarker of immune function. Larger studies are required to confirm our findings.
- 1 March 2025
- Published by IATED Academy in INTED Proceedings
- Vol. 1, 7290-7293
DEVELOPMENT OF NOVEL POLYMER SURFACES FOR IN-VITRO DIAGNOSTIC APPLICATIONS BY MICRO-INJECTION MOULDING
- 1 March 2025
- Published by IATED Academy in INTED Proceedings
- Vol. 1, 7290-7293
DEVELOPMENT OF NOVEL POLYMER SURFACES FOR IN-VITRO DIAGNOSTIC APPLICATIONS BY MICRO-INJECTION MOULDING
- 1 October 2024
- Published by SAGE Publications in Viral Immunology
- Vol. 37 (8) , 404-410
Investigation of SARS-CoV-2 IgG Binding Capability to Variants of the SARS-CoV-2 Virus
The SARS-CoV-2 pandemic has confirmed that the ability to rapidly mutate may be extremely beneficial for a virus. Not long after the first wave, new variants emerged with altered infectivity, disease severity, and mortality. These new strains most notably had numerous mutations of the spike (S) protein, a surface protein responsible for binding to and entering the host cell. The Delta and Omicron strains demonstrated increased immune evasion and improved binding affinity to the host cell receptor, angiotensin-converting enzyme 2 (ACE2). This study examines the ability of wild-type SARS-CoV-2 IgG to bind Delta and Omicron antigens, as well as their functional binding capabilities to two different S-ACE2 complexes. Twenty SARS-CoV-2 positive samples from patients who had recovered from infection with ancestral SARS-CoV-2 in the first wave of COVID-19 and 10 pre-pandemic control samples were studied. SARS-CoV-2 exposed patients showed significantly higher levels of IgG to SARS-CoV-2 S1/RBD (p < 0.001), N protein (p < 0.001), and Omicron spike variant (p = 0.01), but not to Delta spike variant (p = 0.966) when compared with controls. Furthermore, patient samples showed significantly greater inhibition of SARS-CoV-2 S1/RBD and E484K spike to ACE2 binding (p < 0.001 and p = 0.015, respectively). Conversely, there was no correlation between the binding inhibition of S1/RBD and E484K spike to ACE2 receptor. This study shows there is considerable cross-reactivity of IgG generated by wild-type SARS-CoV-2 infection to the Delta and Omicron variants.
- 1 October 2024
- Published by SAGE Publications in Viral Immunology
- Vol. 37 (8) , 404-410
Investigation of SARS-CoV-2 IgG Binding Capability to Variants of the SARS-CoV-2 Virus
The SARS-CoV-2 pandemic has confirmed that the ability to rapidly mutate may be extremely beneficial for a virus. Not long after the first wave, new variants emerged with altered infectivity, disease severity, and mortality. These new strains most notably had numerous mutations of the spike (S) protein, a surface protein responsible for binding to and entering the host cell. The Delta and Omicron strains demonstrated increased immune evasion and improved binding affinity to the host cell receptor, angiotensin-converting enzyme 2 (ACE2). This study examines the ability of wild-type SARS-CoV-2 IgG to bind Delta and Omicron antigens, as well as their functional binding capabilities to two different S-ACE2 complexes. Twenty SARS-CoV-2 positive samples from patients who had recovered from infection with ancestral SARS-CoV-2 in the first wave of COVID-19 and 10 pre-pandemic control samples were studied. SARS-CoV-2 exposed patients showed significantly higher levels of IgG to SARS-CoV-2 S1/RBD (p < 0.001), N protein (p < 0.001), and Omicron spike variant (p = 0.01), but not to Delta spike variant (p = 0.966) when compared with controls. Furthermore, patient samples showed significantly greater inhibition of SARS-CoV-2 S1/RBD and E484K spike to ACE2 binding (p < 0.001 and p = 0.015, respectively). Conversely, there was no correlation between the binding inhibition of S1/RBD and E484K spike to ACE2 receptor. This study shows there is considerable cross-reactivity of IgG generated by wild-type SARS-CoV-2 infection to the Delta and Omicron variants.
- Open Access
- 25 September 2024
- Published by Wiley in Pediatric Transplantation
- Vol. 28 (7) , e14857
Torque Teno Virus Loads as a Marker of Immunosuppression in Pediatric Kidney Transplant Recipients
Background: Long‐term renal function and survival after kidney transplantation rely on appropriate immunosuppressive treatment to prevent the risk of rejection. New biomarkers are needed to accurately assess the degree of immunosuppression in renal transplant recipients in order to avoid organ rejection and the development of opportunistic infections. Highly prevalent in humans, torque teno virus (TTV), which belongs to the family Anelloviridae, is a small, nonenveloped, single‐stranded DNA virus which has not been linked with any specific human illness, but which constitutes a major component of the human virome. Host antiviral responses allow TTV levels to be controlled; however, viral persistence remains, explaining the high prevalence in human populations, including healthy individuals. Important confounders of TTV load include time since transplantation, age, gender, obesity, and smoking status.Aims: TTV‐based guidance of immunosuppressive drug dosing could help with risk stratification, reducing the risk of infection, graft rejection and oncologic disease on an individual level, enabling long‐term patient and graft survival.Methods: Original studies were accessed by a systematic search from electronic databases including PubMed, ScienceDirect and Wiley Online Library.Results: The presented data mainly derive from adult transplant recipients showing an association between TTV plasma levels and the immune status of the host: High‐TTV load and high immunosuppression are associated with a risk of infection, and low‐TTV load and low immunosuppression indicate a risk of rejection. However, there is minimal information on pediatric transplant recipients with further research required in this cohort. To date, it has been demonstrated that longer posttransplant times are significantly associated with lower TTV levels in children with renal transplant. Meanwhile, an association between lower TTV loads and increased risk of graft reject during the first year of transplantation was also reported. More recently, Eibensteiner et al. revealed a robust, independent association between TTV plasma load and the onset of Cytomegalovirus and BK virus infections.Conclusion: Data from randomized controlled trials are still missing, even in adults, but a multicenter randomized controlled trial for TTV‐guided immunosuppression in adult kidney recipients (TTVguideIT) began in 2022. There is, therefore, great promise for TTV levels to be used as a biomarker that could potentially improve both graft and patient survival in transplantation.
- 25 September 2024
- Published by Wiley in Pediatric Transplantation
- Vol. 28 (7) , e14857
Open AccessTorque Teno Virus Loads as a Marker of Immunosuppression in Pediatric Kidney Transplant Recipients
Background: Long‐term renal function and survival after kidney transplantation rely on appropriate immunosuppressive treatment to prevent the risk of rejection. New biomarkers are needed to accurately assess the degree of immunosuppression in renal transplant recipients in order to avoid organ rejection and the development of opportunistic infections. Highly prevalent in humans, torque teno virus (TTV), which belongs to the family Anelloviridae, is a small, nonenveloped, single‐stranded DNA virus which has not been linked with any specific human illness, but which constitutes a major component of the human virome. Host antiviral responses allow TTV levels to be controlled; however, viral persistence remains, explaining the high prevalence in human populations, including healthy individuals. Important confounders of TTV load include time since transplantation, age, gender, obesity, and smoking status.Aims: TTV‐based guidance of immunosuppressive drug dosing could help with risk stratification, reducing the risk of infection, graft rejection and oncologic disease on an individual level, enabling long‐term patient and graft survival.Methods: Original studies were accessed by a systematic search from electronic databases including PubMed, ScienceDirect and Wiley Online Library.Results: The presented data mainly derive from adult transplant recipients showing an association between TTV plasma levels and the immune status of the host: High‐TTV load and high immunosuppression are associated with a risk of infection, and low‐TTV load and low immunosuppression indicate a risk of rejection. However, there is minimal information on pediatric transplant recipients with further research required in this cohort. To date, it has been demonstrated that longer posttransplant times are significantly associated with lower TTV levels in children with renal transplant. Meanwhile, an association between lower TTV loads and increased risk of graft reject during the first year of transplantation was also reported. More recently, Eibensteiner et al. revealed a robust, independent association between TTV plasma load and the onset of Cytomegalovirus and BK virus infections.Conclusion: Data from randomized controlled trials are still missing, even in adults, but a multicenter randomized controlled trial for TTV‐guided immunosuppression in adult kidney recipients (TTVguideIT) began in 2022. There is, therefore, great promise for TTV levels to be used as a biomarker that could potentially improve both graft and patient survival in transplantation.
- Open Access
- 14 November 2023
- Published by Elsevier in Journal of Clinical Virology Plus
- Vol. 4 (1)
Longitudinal analysis of the impact of rituximab on circulating EBV miRNAs in three paediatric kidney transplant recipients
- 14 November 2023
- Published by Elsevier in Journal of Clinical Virology Plus
- Vol. 4 (1)
Open AccessLongitudinal analysis of the impact of rituximab on circulating EBV miRNAs in three paediatric kidney transplant recipients
- Open Access
- 1 August 2020
- Published by Elsevier in Journal of Clinical Virology
- Vol. 129, 104517
Presence of low mumps-specific IgG in oral fluids is associated with high mumps viral loads
- 1 August 2020
- Published by Elsevier in Journal of Clinical Virology
- Vol. 129, 104517
Open AccessPresence of low mumps-specific IgG in oral fluids is associated with high mumps viral loads
- 1 June 2020
- Published by Elsevier in Journal of Clinical Virology
- Vol. 127, 104368
The prevalence of Human polyomavirus 2 (HPyV2) antibody positivity in psoriasis patients
- 1 June 2020
- Published by Elsevier in Journal of Clinical Virology
- Vol. 127, 104368
The prevalence of Human polyomavirus 2 (HPyV2) antibody positivity in psoriasis patients
- 11 March 2019
- Published by Springer Nature in Medical Microbiology and Immunology
- Vol. 208 (5) , 693-702
Discrimination between recent and non-recent HIV infections using routine diagnostic serological assays
The suitability of routine diagnostic HIV assays to accurately discriminate between recent and non-recent HIV infections has not been fully investigated. The aim of this study was to compare an established HIV recency assay, the Sedia limiting antigen HIV avidity assay (LAg), with the diagnostic assays; Abbott ARCHITECT HIV Ag/Ab Combo and INNO-LIA HIV line assays. Samples from all new HIV diagnoses in Ireland from January to December 2016 (n = 455) were tested. An extended logistic regression model, the Spiegelhalter–Knill–Jones method, was utilised to establish a scoring system to predict recency of HIV infection. As proof of concept, 50 well-characterised samples were obtained from the CEPHIA repository whose stage of infection was blinded to the authors, which were tested and analysed. The proportion of samples that were determined as recent was 18.1% for LAg, 6.4% with the ARCHITECT, and 14.5% in the INNO-LIA assay. There was a significant correlation between the ARCHITECT S/CO values and the LAg results, r = 0.717, p < 0.001. ROC analysis revealed that an ARCHITECT S/CO < 250 had a sensitivity and specificity of 90.32% and 89.83%, respectively. Combining the Abbott ARCHITECT HIV Ag/Ab Combo assay and INNO-LIA HIV assays resulted in an observed risk of being recent of 100%. Analysis of the CEPHIA samples revealed a strong agreement between the LAg assay and the combination of routine assays (κ = 0.908, p < 0.001). Our findings provide evidence that assays routinely employed to diagnose and confirm HIV infection may be utilised to determine the recency of HIV infection.
- 11 March 2019
- Published by Springer Nature in Medical Microbiology and Immunology
- Vol. 208 (5) , 693-702
Discrimination between recent and non-recent HIV infections using routine diagnostic serological assays
The suitability of routine diagnostic HIV assays to accurately discriminate between recent and non-recent HIV infections has not been fully investigated. The aim of this study was to compare an established HIV recency assay, the Sedia limiting antigen HIV avidity assay (LAg), with the diagnostic assays; Abbott ARCHITECT HIV Ag/Ab Combo and INNO-LIA HIV line assays. Samples from all new HIV diagnoses in Ireland from January to December 2016 (n = 455) were tested. An extended logistic regression model, the Spiegelhalter–Knill–Jones method, was utilised to establish a scoring system to predict recency of HIV infection. As proof of concept, 50 well-characterised samples were obtained from the CEPHIA repository whose stage of infection was blinded to the authors, which were tested and analysed. The proportion of samples that were determined as recent was 18.1% for LAg, 6.4% with the ARCHITECT, and 14.5% in the INNO-LIA assay. There was a significant correlation between the ARCHITECT S/CO values and the LAg results, r = 0.717, p < 0.001. ROC analysis revealed that an ARCHITECT S/CO < 250 had a sensitivity and specificity of 90.32% and 89.83%, respectively. Combining the Abbott ARCHITECT HIV Ag/Ab Combo assay and INNO-LIA HIV assays resulted in an observed risk of being recent of 100%. Analysis of the CEPHIA samples revealed a strong agreement between the LAg assay and the combination of routine assays (κ = 0.908, p < 0.001). Our findings provide evidence that assays routinely employed to diagnose and confirm HIV infection may be utilised to determine the recency of HIV infection.
- Open Access
- 4 March 2019
- Published by Cambridge University Press (CUP) in Epidemiology and Infection
- Vol. 147, e136
Integration of a recent infection testing algorithm into HIV surveillance in Ireland: improving HIV knowledge to target prevention
Recent infection testing algorithms (RITA) for HIV combine serological assays with epidemiological data to determine likely recent infections, indicators of ongoing transmission. In 2016, we integrated RITA into national HIV surveillance in Ireland to better inform HIV prevention interventions. We determined the avidity index (AI) of new HIV diagnoses and linked the results with data captured in the national infectious disease reporting system. RITA classified a diagnosis as recent based on an AI < 1.5, unless epidemiological criteria (CD4 count 3; viral load <400 copies/ml; the presence of AIDS-defining illness; prior antiretroviral therapy use) indicated a potential false-recent result. Of 508 diagnoses in 2016, we linked 448 (88.1%) to an avidity test result. RITA classified 12.5% of diagnoses as recent, with the highest proportion (26.3%) amongst people who inject drugs. On multivariable logistic regression recent infection was more likely with a concurrent sexually transmitted infection (aOR 2.59; 95% CI 1.04–6.45). Data were incomplete for at least one RITA criterion in 48% of cases. The study demonstrated the feasibility of integrating RITA into routine surveillance and showed some ongoing HIV transmission. To improve the interpretation of RITA, further efforts are required to improve completeness of the required epidemiological data.
- 4 March 2019
- Published by Cambridge University Press (CUP) in Epidemiology and Infection
- Vol. 147, e136
Open AccessIntegration of a recent infection testing algorithm into HIV surveillance in Ireland: improving HIV knowledge to target prevention
Recent infection testing algorithms (RITA) for HIV combine serological assays with epidemiological data to determine likely recent infections, indicators of ongoing transmission. In 2016, we integrated RITA into national HIV surveillance in Ireland to better inform HIV prevention interventions. We determined the avidity index (AI) of new HIV diagnoses and linked the results with data captured in the national infectious disease reporting system. RITA classified a diagnosis as recent based on an AI < 1.5, unless epidemiological criteria (CD4 count 3; viral load <400 copies/ml; the presence of AIDS-defining illness; prior antiretroviral therapy use) indicated a potential false-recent result. Of 508 diagnoses in 2016, we linked 448 (88.1%) to an avidity test result. RITA classified 12.5% of diagnoses as recent, with the highest proportion (26.3%) amongst people who inject drugs. On multivariable logistic regression recent infection was more likely with a concurrent sexually transmitted infection (aOR 2.59; 95% CI 1.04–6.45). Data were incomplete for at least one RITA criterion in 48% of cases. The study demonstrated the feasibility of integrating RITA into routine surveillance and showed some ongoing HIV transmission. To improve the interpretation of RITA, further efforts are required to improve completeness of the required epidemiological data.